Article
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men
24 Jun 2013
Abstract excerpt
Controversy surrounds the use of PSA as a biomarker for prostate cancer detection, leaving an unmet need for a novel biomarker in this setting; urinary EN2 may identify individuals with clinically relevant prostate cancer. Male BRCA1 and BRCA2 mutation carriers are at increased risk of clinically significant prostate cancer and may benefit from screening. Urine samples from 413 BRCA1 and BRCA2 mutation carriers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
